Contrôle pharmacologique de la voie de biosynthèse du mévalonate: effet sur la prolifération de cellules musculaires lisses artérielles.

Translated title of the contribution: Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells

A. Corsini, L. Arnaboldi, P. Quarato, N. Ferri, A. Granata, R. Fumagalli, R. Paoletti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The role of mevalonic acid (MVA) and its products (isoprenoids) in cell proliferation prompted us to investigate the effect of drugs affecting diverse enzymatic steps of the MVA pathway on rat aorta smooth muscle cell (SMC) proliferation. Competitive inhibitors of HMG-CoA reductase (statins) decreased SMC proliferation in a dose-dependent manner. The inhibitory effect induced by simvastatin 3.5 microM (70% +/- 3.8 decrease) was prevented by addition of 100 microM MVA, (100% +/- 2.3), 10 microM farnesol (F-OH) (85% +/- 1.2) and 5 microM of all-trans geranylgeraniol (GG-OH) (precursor of prenylated proteins) (81% +/- 1.1), but not by 2-cis GG-OH (precursor of dolichols), squalene and ubiquinone. The same inhibitory effect was obtained with 6-fluoromevalonate (1-50 microM), an inhibitor of MVA-PP decarboxylase. Squalestatin 1 (1-25 microM) and NB-598 (1-10 microM), potent squalene synthase and epoxidase inhibitors, respectively, caused a complete inhibition of cholesterol synthesis without affecting SMC proliferation. Finally, BZA-5B (10-50 microM) a specific inhibitor of protein farnesyl tranferase (PFTase), inhibited SMC proliferation in a dose- (10-50 microM) and time-dependent manner, reaching 52% +/- 6.3 inhibition after 9 days, in the presence of 50 microM BZA-5B, without affecting cholesterol synthesis. This effect was partially prevented by mevalonate (76% +/- 3.2) and GG-OH (87% +/- 7.3) but not by F-OH. On the other hand, SMC proliferation was not affected by the closely related compound BZA-7B (93% +/- 4), which does not inhibit PFTase. Taken together, these findings support the involvement of specific isoprenoid metabolites, probably through farnesylated and geranylgeranylated proteins in cell proliferation.

Original languageFrench
Pages (from-to)169-194
Number of pages26
JournalComptes rendus des séances de la Société de biologie et de ses filiales
Volume191
Issue number2
Publication statusPublished - 1997

Fingerprint

Mevalonic Acid
Biosynthesis
Cell proliferation
Smooth Muscle Myocytes
Muscle
Cells
Cell Proliferation
Pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Terpenes
Squalene Monooxygenase
Proteins
Farnesyl-Diphosphate Farnesyltransferase
Cholesterol
Farnesol
Dolichol
Squalene
Ubiquinone
Carboxy-Lyases
Simvastatin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Contrôle pharmacologique de la voie de biosynthèse du mévalonate : effet sur la prolifération de cellules musculaires lisses artérielles. / Corsini, A.; Arnaboldi, L.; Quarato, P.; Ferri, N.; Granata, A.; Fumagalli, R.; Paoletti, R.

In: Comptes rendus des séances de la Société de biologie et de ses filiales, Vol. 191, No. 2, 1997, p. 169-194.

Research output: Contribution to journalArticle

Corsini, A. ; Arnaboldi, L. ; Quarato, P. ; Ferri, N. ; Granata, A. ; Fumagalli, R. ; Paoletti, R. / Contrôle pharmacologique de la voie de biosynthèse du mévalonate : effet sur la prolifération de cellules musculaires lisses artérielles. In: Comptes rendus des séances de la Société de biologie et de ses filiales. 1997 ; Vol. 191, No. 2. pp. 169-194.
@article{9f290fffb6e046fab99c0fe99008a703,
title = "Contr{\^o}le pharmacologique de la voie de biosynth{\`e}se du m{\'e}valonate: effet sur la prolif{\'e}ration de cellules musculaires lisses art{\'e}rielles.",
abstract = "The role of mevalonic acid (MVA) and its products (isoprenoids) in cell proliferation prompted us to investigate the effect of drugs affecting diverse enzymatic steps of the MVA pathway on rat aorta smooth muscle cell (SMC) proliferation. Competitive inhibitors of HMG-CoA reductase (statins) decreased SMC proliferation in a dose-dependent manner. The inhibitory effect induced by simvastatin 3.5 microM (70{\%} +/- 3.8 decrease) was prevented by addition of 100 microM MVA, (100{\%} +/- 2.3), 10 microM farnesol (F-OH) (85{\%} +/- 1.2) and 5 microM of all-trans geranylgeraniol (GG-OH) (precursor of prenylated proteins) (81{\%} +/- 1.1), but not by 2-cis GG-OH (precursor of dolichols), squalene and ubiquinone. The same inhibitory effect was obtained with 6-fluoromevalonate (1-50 microM), an inhibitor of MVA-PP decarboxylase. Squalestatin 1 (1-25 microM) and NB-598 (1-10 microM), potent squalene synthase and epoxidase inhibitors, respectively, caused a complete inhibition of cholesterol synthesis without affecting SMC proliferation. Finally, BZA-5B (10-50 microM) a specific inhibitor of protein farnesyl tranferase (PFTase), inhibited SMC proliferation in a dose- (10-50 microM) and time-dependent manner, reaching 52{\%} +/- 6.3 inhibition after 9 days, in the presence of 50 microM BZA-5B, without affecting cholesterol synthesis. This effect was partially prevented by mevalonate (76{\%} +/- 3.2) and GG-OH (87{\%} +/- 7.3) but not by F-OH. On the other hand, SMC proliferation was not affected by the closely related compound BZA-7B (93{\%} +/- 4), which does not inhibit PFTase. Taken together, these findings support the involvement of specific isoprenoid metabolites, probably through farnesylated and geranylgeranylated proteins in cell proliferation.",
author = "A. Corsini and L. Arnaboldi and P. Quarato and N. Ferri and A. Granata and R. Fumagalli and R. Paoletti",
year = "1997",
language = "Francese",
volume = "191",
pages = "169--194",
journal = "Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales",
issn = "0037-9026",
publisher = "Masson Publishing",
number = "2",

}

TY - JOUR

T1 - Contrôle pharmacologique de la voie de biosynthèse du mévalonate

T2 - effet sur la prolifération de cellules musculaires lisses artérielles.

AU - Corsini, A.

AU - Arnaboldi, L.

AU - Quarato, P.

AU - Ferri, N.

AU - Granata, A.

AU - Fumagalli, R.

AU - Paoletti, R.

PY - 1997

Y1 - 1997

N2 - The role of mevalonic acid (MVA) and its products (isoprenoids) in cell proliferation prompted us to investigate the effect of drugs affecting diverse enzymatic steps of the MVA pathway on rat aorta smooth muscle cell (SMC) proliferation. Competitive inhibitors of HMG-CoA reductase (statins) decreased SMC proliferation in a dose-dependent manner. The inhibitory effect induced by simvastatin 3.5 microM (70% +/- 3.8 decrease) was prevented by addition of 100 microM MVA, (100% +/- 2.3), 10 microM farnesol (F-OH) (85% +/- 1.2) and 5 microM of all-trans geranylgeraniol (GG-OH) (precursor of prenylated proteins) (81% +/- 1.1), but not by 2-cis GG-OH (precursor of dolichols), squalene and ubiquinone. The same inhibitory effect was obtained with 6-fluoromevalonate (1-50 microM), an inhibitor of MVA-PP decarboxylase. Squalestatin 1 (1-25 microM) and NB-598 (1-10 microM), potent squalene synthase and epoxidase inhibitors, respectively, caused a complete inhibition of cholesterol synthesis without affecting SMC proliferation. Finally, BZA-5B (10-50 microM) a specific inhibitor of protein farnesyl tranferase (PFTase), inhibited SMC proliferation in a dose- (10-50 microM) and time-dependent manner, reaching 52% +/- 6.3 inhibition after 9 days, in the presence of 50 microM BZA-5B, without affecting cholesterol synthesis. This effect was partially prevented by mevalonate (76% +/- 3.2) and GG-OH (87% +/- 7.3) but not by F-OH. On the other hand, SMC proliferation was not affected by the closely related compound BZA-7B (93% +/- 4), which does not inhibit PFTase. Taken together, these findings support the involvement of specific isoprenoid metabolites, probably through farnesylated and geranylgeranylated proteins in cell proliferation.

AB - The role of mevalonic acid (MVA) and its products (isoprenoids) in cell proliferation prompted us to investigate the effect of drugs affecting diverse enzymatic steps of the MVA pathway on rat aorta smooth muscle cell (SMC) proliferation. Competitive inhibitors of HMG-CoA reductase (statins) decreased SMC proliferation in a dose-dependent manner. The inhibitory effect induced by simvastatin 3.5 microM (70% +/- 3.8 decrease) was prevented by addition of 100 microM MVA, (100% +/- 2.3), 10 microM farnesol (F-OH) (85% +/- 1.2) and 5 microM of all-trans geranylgeraniol (GG-OH) (precursor of prenylated proteins) (81% +/- 1.1), but not by 2-cis GG-OH (precursor of dolichols), squalene and ubiquinone. The same inhibitory effect was obtained with 6-fluoromevalonate (1-50 microM), an inhibitor of MVA-PP decarboxylase. Squalestatin 1 (1-25 microM) and NB-598 (1-10 microM), potent squalene synthase and epoxidase inhibitors, respectively, caused a complete inhibition of cholesterol synthesis without affecting SMC proliferation. Finally, BZA-5B (10-50 microM) a specific inhibitor of protein farnesyl tranferase (PFTase), inhibited SMC proliferation in a dose- (10-50 microM) and time-dependent manner, reaching 52% +/- 6.3 inhibition after 9 days, in the presence of 50 microM BZA-5B, without affecting cholesterol synthesis. This effect was partially prevented by mevalonate (76% +/- 3.2) and GG-OH (87% +/- 7.3) but not by F-OH. On the other hand, SMC proliferation was not affected by the closely related compound BZA-7B (93% +/- 4), which does not inhibit PFTase. Taken together, these findings support the involvement of specific isoprenoid metabolites, probably through farnesylated and geranylgeranylated proteins in cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=0030629594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030629594&partnerID=8YFLogxK

M3 - Articolo

C2 - 9255346

AN - SCOPUS:0030629594

VL - 191

SP - 169

EP - 194

JO - Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales

JF - Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales

SN - 0037-9026

IS - 2

ER -